[go: up one dir, main page]

AR029317A1 - UN PROCEDIMIENTO PARA PREPARAR UNA COMPOSICIoN FARMACÉUTICA QUE COMPRENDE UN SENSIBILIZADOR DE INSULINA. - Google Patents

UN PROCEDIMIENTO PARA PREPARAR UNA COMPOSICIoN FARMACÉUTICA QUE COMPRENDE UN SENSIBILIZADOR DE INSULINA.

Info

Publication number
AR029317A1
AR029317A1 ARP990105701A ARP990105701A AR029317A1 AR 029317 A1 AR029317 A1 AR 029317A1 AR P990105701 A ARP990105701 A AR P990105701A AR P990105701 A ARP990105701 A AR P990105701A AR 029317 A1 AR029317 A1 AR 029317A1
Authority
AR
Argentina
Prior art keywords
insulin sensitizer
pharmaceutical composition
prepare
procedure
insulin
Prior art date
Application number
ARP990105701A
Other languages
English (en)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10842389&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR029317(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of AR029317A1 publication Critical patent/AR029317A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)

Abstract

Un procedimiento para preparar una composicion farmacéutica, que comprende un sensibilizador de insulina y un vehículo farmacéuticamente aceptable para el mismo, adaptándose la composicion para proporcionar una concentracion plasmática del sensibilizador de insulina al menos igual a insulina que comprende formular el sensibilizador de insulina y el vehículo farmacéuticamente aceptable con objeto de proporcionar una concentracion plasmática del sensibilizador de insulina al menos igual a una concentracion plasmática umbral del sensibilizador de insulina.
ARP990105701A 1998-11-12 1999-11-10 UN PROCEDIMIENTO PARA PREPARAR UNA COMPOSICIoN FARMACÉUTICA QUE COMPRENDE UN SENSIBILIZADOR DE INSULINA. AR029317A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9824893.3A GB9824893D0 (en) 1998-11-12 1998-11-12 Novel method of treatment

Publications (1)

Publication Number Publication Date
AR029317A1 true AR029317A1 (es) 2003-06-25

Family

ID=10842389

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP990105701A AR029317A1 (es) 1998-11-12 1999-11-10 UN PROCEDIMIENTO PARA PREPARAR UNA COMPOSICIoN FARMACÉUTICA QUE COMPRENDE UN SENSIBILIZADOR DE INSULINA.
ARP990105700A AR029149A1 (es) 1998-11-12 1999-11-10 USO DE UN SENSIBILIZADOR DE INSULINA, UNA COMPOSICIoN FARMACÉUTICA Y UN MÉTODO PARA DETERMINAR LA CONCENTRACIoN PLASMA TICA UMBRAL PARA UN COMPUESTO ANTIDIABÉTICO.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP990105700A AR029149A1 (es) 1998-11-12 1999-11-10 USO DE UN SENSIBILIZADOR DE INSULINA, UNA COMPOSICIoN FARMACÉUTICA Y UN MÉTODO PARA DETERMINAR LA CONCENTRACIoN PLASMA TICA UMBRAL PARA UN COMPUESTO ANTIDIABÉTICO.

Country Status (40)

Country Link
EP (2) EP1135128B1 (es)
JP (1) JP2003521455A (es)
KR (2) KR20010080440A (es)
CN (3) CN1771943A (es)
AP (2) AP2005003432A0 (es)
AR (2) AR029317A1 (es)
AT (1) ATE366573T1 (es)
AU (1) AU768303B2 (es)
BG (2) BG110061A (es)
BR (1) BR9915284A (es)
CA (1) CA2350425C (es)
CO (1) CO5150158A1 (es)
CY (1) CY1106892T1 (es)
CZ (1) CZ299801B6 (es)
DE (1) DE69936533T2 (es)
DK (1) DK1135128T3 (es)
DZ (1) DZ2938A1 (es)
EA (2) EA200700968A1 (es)
ES (1) ES2289833T3 (es)
GB (1) GB9824893D0 (es)
HK (1) HK1041202B (es)
HR (1) HRP20010344B1 (es)
HU (1) HUP0104262A3 (es)
IL (1) IL143088A0 (es)
MA (1) MA26759A1 (es)
MY (1) MY128347A (es)
NO (1) NO328391B1 (es)
NZ (1) NZ527132A (es)
OA (1) OA12193A (es)
PE (1) PE20001239A1 (es)
PL (1) PL349421A1 (es)
PT (1) PT1135128E (es)
RS (1) RS50130B (es)
SK (1) SK286357B6 (es)
TR (1) TR200101348T2 (es)
TW (1) TWI234456B (es)
UA (1) UA79730C2 (es)
UY (2) UY25797A1 (es)
WO (1) WO2000027341A2 (es)
ZA (1) ZA200103793B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY125516A (en) 1999-11-16 2006-08-30 Smithkline Beecham Plc Novel composition based on thiazolidinedione and metformin and use
ES2259736T3 (es) * 2001-12-21 2006-10-16 Smithkline Beecham Corporation Regimen de dosificacion para activadores de ppar-gamma-.
WO2012074375A1 (en) * 2010-12-01 2012-06-07 N.V. Nutricia Prevention or treatment of overweight and obesity in type 2 diabetic patients

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS5697277A (en) * 1980-01-07 1981-08-05 Takeda Chem Ind Ltd Thiazolidine derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4582839A (en) * 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
ES2137915T3 (es) * 1987-09-04 2000-01-01 Beecham Group Plc Derivados de tiazolidindiona sustituida.
US4791125A (en) * 1987-12-02 1988-12-13 Pfizer Inc. Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
WO1989008651A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
US5061717A (en) * 1988-03-08 1991-10-29 Pfizer Inc. Thiazolidinedione hypoglycemic agents
GB8919417D0 (en) * 1989-08-25 1989-10-11 Beecham Group Plc Novel compounds
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
JPH0469331A (ja) * 1990-07-10 1992-03-04 Asahi Chem Ind Co Ltd 徐放性エマルジョン製剤
JP2572673B2 (ja) * 1990-07-25 1997-01-16 エスエス製薬株式会社 徐放性錠剤
JPH04210683A (ja) * 1990-12-06 1992-07-31 Terumo Corp チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
US5183823A (en) * 1991-04-11 1993-02-02 Takeda Chemical Industries, Ltd. Pyridine n-oxide compounds which are useful as hypoglycemic and hypolipidemic agents
FR2680512B1 (fr) * 1991-08-20 1995-01-20 Adir Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
EP0601001B1 (en) * 1991-08-26 1997-04-16 PHARMACIA & UPJOHN COMPANY Liquid food product containing 3-guanidinopropionic acid
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5478853A (en) * 1992-10-12 1995-12-26 Adir Et Compagnie Thazolidinedione compounds
US5506245A (en) * 1992-10-12 1996-04-09 Adir Et Compagnie Thiazolidinedione compounds
CA2115587A1 (en) * 1993-02-18 1994-08-19 Hayato Kihara Styrene copolymers, polystyrene compositions, processes for producing styrene copolymers, and injection-molded articles
DE4317320A1 (de) * 1993-05-25 1994-12-01 Boehringer Mannheim Gmbh Neue Thiazolidindione und diese enthaltende Arzneimittel
JP3081245B2 (ja) * 1993-09-15 2000-08-28 三共株式会社 Ｎｉｄｄｍの発症を阻止又は遅延するためのチアゾリジンジオン類の用途
US5478852C1 (en) * 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus
US5902726A (en) * 1994-12-23 1999-05-11 Glaxo Wellcome Inc. Activators of the nuclear orphan receptor peroxisome proliferator-activated receptor gamma
US5708012A (en) * 1995-04-28 1998-01-13 Sankyo Company, Limited Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of insulin resistant subjects with normal glucose tolerance in order to prevent or delay the onset of noninsulin-dependent mellitus
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
US5859037A (en) * 1997-02-19 1999-01-12 Warner-Lambert Company Sulfonylurea-glitazone combinations for diabetes

Also Published As

Publication number Publication date
NO20012301D0 (no) 2001-05-10
MY128347A (en) 2007-01-31
IL143088A0 (en) 2002-11-10
DE69936533T2 (de) 2008-03-13
CN1771943A (zh) 2006-05-17
NO328391B1 (no) 2010-02-08
AU768303B2 (en) 2003-12-04
AP2005003432A0 (en) 2005-12-31
CA2350425C (en) 2009-06-02
UY25801A1 (es) 2000-08-21
HK1041202B (zh) 2007-10-05
ATE366573T1 (de) 2007-08-15
EA200100539A1 (ru) 2001-12-24
CA2350425A1 (en) 2000-05-18
KR20070048279A (ko) 2007-05-08
DE69936533D1 (de) 2007-08-23
JP2003521455A (ja) 2003-07-15
CZ20011656A3 (cs) 2002-06-12
NO20012301L (no) 2001-07-09
KR20010080440A (ko) 2001-08-22
DZ2938A1 (fr) 2004-03-15
PT1135128E (pt) 2007-10-12
GB9824893D0 (en) 1999-01-06
CN101244062A (zh) 2008-08-20
HK1041202A1 (en) 2002-07-05
YU37401A (sh) 2005-07-19
WO2000027341A3 (en) 2000-09-08
BG65577B1 (bg) 2009-01-30
ES2289833T3 (es) 2008-02-01
EA009192B1 (ru) 2007-12-28
CY1106892T1 (el) 2012-01-25
DK1135128T3 (da) 2007-11-05
HRP20010344A2 (en) 2002-06-30
PE20001239A1 (es) 2000-12-24
NZ527132A (en) 2005-01-28
SK286357B6 (sk) 2008-08-05
TR200101348T2 (tr) 2002-02-21
MA26759A1 (fr) 2004-12-20
CO5150158A1 (es) 2002-04-29
TWI234456B (en) 2005-06-21
RS50130B (sr) 2009-03-25
CN1354661A (zh) 2002-06-19
UA79730C2 (en) 2007-07-25
HRP20010344B1 (en) 2008-02-29
AP1580A (en) 2006-02-24
BG110061A (bg) 2008-12-30
EA200700968A1 (ru) 2008-06-30
AR029149A1 (es) 2003-06-18
EP1135128A4 (en) 2003-07-16
PL349421A1 (en) 2002-07-29
EP1135128A2 (en) 2001-09-26
WO2000027341A2 (en) 2000-05-18
UY25797A1 (es) 2000-12-29
BR9915284A (pt) 2002-02-13
EP1135128B1 (en) 2007-07-11
HUP0104262A3 (en) 2003-06-30
CZ299801B6 (cs) 2008-11-26
EP1759698A1 (en) 2007-03-07
AU1719600A (en) 2000-05-29
SK6422001A3 (en) 2001-12-03
ZA200103793B (en) 2002-06-05
CN1235586C (zh) 2006-01-11
BG105569A (en) 2002-01-31
HUP0104262A2 (en) 2002-08-28
OA12193A (en) 2006-05-09

Similar Documents

Publication Publication Date Title
AR035500A1 (es) Uso de clorpromazina y pentamidina para la fabricacion de medicamentos, composicion farmaceutica y paquete farmaceutico que comprenden clorpromazina y pentamidina.
YU37301A (sh) Farmaceutski preparat za modifikovano oslobađanje sensitizera insulina i drugog antidijabetskog agensa
SV2004001556A (es) Preparaciones acidas de insulina con establidad mejorada
ES2138271T3 (es) Compuestos de 6-dimetil-amino-metil-1-fenil-ciclohexano como principio activo farmaceutico.
AR023700A1 (es) Un procedimiento para preparar una composicion farmaceutica que comprende un sensibilizador de insulina
IL131651A0 (en) A pharmaceutical formulation containing benzimidazoles with amino acid/caclodextrin combinations and a process for producing the same
AR002614A1 (es) Nuevo preparado medicamentoso estable para la produccion de aerosoles exentos de gas propulsor
ES2194989T3 (es) Composicion adminstrada por via oral, que comprende una toxina de zonula occludens y un agente que tiene una actividad biologica, y su utilizacion.
DE60019334D1 (de) Antivirale arznei
GB2380675A (en) Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives
CL2009001899A1 (es) Composicion farmaceutica que comprende: i) un antagonista del receptor de at1 o una sal, ii) un sensibilizante a la insulina o una sal y iii) un vehiculo farmaceuticamente aceptable; uso para la prevencion, demora de progreso o tratamiento de hipertension, diabetes, entre otras (div. sol. 2034-01).
ES2190205T3 (es) Combinacion para el tratamiento de la dependencia del alcohol que contiene un antagonista opioide y un modulador del complejo receptor de nmda.
ES2089687T3 (es) 4-fenil-piridonas y 4-fenil-2-alcoxipiridinas sustituidas como inhibidores de la hmg-coa-reductasa.
DE69924004D1 (de) Verabreichungssystem für wasserunlösliche arzneistoffe
CO5280222A1 (es) Composicion farmaceutica que comprende pemetrexed
AU2001261516A1 (en) Semi-solid delivery vehicle and pharmaceutical compositions
ATE450254T1 (de) Schwimmende pharmazeutische zusammensetzung mit einer aktiven phase und einer inaktiven phase
AR029317A1 (es) UN PROCEDIMIENTO PARA PREPARAR UNA COMPOSICIoN FARMACÉUTICA QUE COMPRENDE UN SENSIBILIZADOR DE INSULINA.
UY26171A1 (es) Método y formulación farmacéutica para el tratamiento de la discinesia de aparición tardía
AR019724A2 (es) Composicion farmaceutica util para el tratamiento de diabetes mellitus y condiciones asociadas
AR019331A2 (es) Composicion farmaceutica que contiene un sensibilizador a insulina y un secretagogo de insulina.
AR017455A1 (es) Composiciones farmaceuticas que comprenden (1s,4r)-cis-4-[2-amino-6-ciclopropilamino)-9h-purin-9-ilo]-2-ciclopenten-1-metanol, un quelante de metal y un agente edulcorante
DE60039122D1 (de) 6-o-alkyl-2-nor-2-substituierte ketolidderivate
ES2136965T3 (es) Derivados de 17-hidroxiiminoalquil y 17-hidroxiiminometilalquenil ciclopentanperhidrofenantreno activos sobre el sistema cardiovascular un procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2156824B1 (es) Aparato de distribucion para objetos a orientar longiotudinalmente en un sentido

Legal Events

Date Code Title Description
FB Suspension of granting procedure